Home > News > Eiffel to accelerate drug re-engineering efforts
June 3rd, 2004
Eiffel to accelerate drug re-engineering efforts
Abstract:
Eiffel said it plans to use its Supercritical Fluid (SCF) technology, designed to improve the efficacy of drugs and extend their patent life by reforming them into nano-sized particles that are easier for the body to absorb, in the area of asthma.
Source:
inpharma
Bookmark:
| Related News Press |
Nanomedicine
Tumor microenvironment dynamics: the regulatory influence of long non-coding RNAs April 25th, 2025
Next-generation drug delivery innovation! DGIST develops precision therapeutics using exosomes April 25th, 2025
Multiphoton polymerization: A promising technology for precision medicine February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||